An evidence for regulatory cross-talk between aryl hydrocarbon receptor and glucocorticoid receptor in HepG2 cells

Physiological Research

Volumn 57, Issue 3, 2008, Pages 427-435

  Dvořák, Zdeněk ^a   Vrzal, R ^a   Pavek P ^b   Ulrichova J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Cellular signaling; Dioxin; Glucocorticoids; Nuclear receptors; Transcriptional control; Xenobiotics

Indexed keywords

EID: 40849108656     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ABBOTT BD: Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology 105: 365-373, 1995.
2. ABBOTT BD, PERDEW GH, BUCKALEW AR, BIRNBAUM LS: Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Appl Pharmacol 128: 138-150, 1994.
3. ABBOTT BD, PROBST MR, PERDEW GH, BUCKALEW AR: AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58: 30-43, 1998.
4. ABBOTT BD, SCHMID JE, BROWN JG, WOOD CR, WHITE RD, BUCKALEW AR, HELD GA: RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Sci 47: 76-85, 1999.
5. ABEL GA, WOCHNIK GM, RUEGG J, ROUYER A, HOLSBOER F, REIN T: Activity of the GR in G2 and mitosis. Mol Endocrinol 16: 1352-1366, 2002.
6. ALURU N, RENAUD R, LEATHERLAND JF, VIJAYAN MM: Ah Receptor-mediated impairment of interrenal steroidogenesis involves StAR protein and P450scc gene attenuation in rainbow trout. Toxicol Sci 84: 260-269, 2005.
7. ALURU N, VIJAYAN MM: beta-Naphthoflavone disrupts cortisol production and liver glucocorticoid responsiveness in rainbow trout. Aquat Toxicol 67: 273-285, 2004.
8. BACKLUND M, JOHANSSON I, MKRTCHIAN S, INGELMAN-SUNDBERG M: Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. J Biol Chem 272: 31755-31763, 1997.
9. BAROUKI R, MOREL Y: Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 61: 511-516, 2001.
10. BODWELL JE, WEBSTER JC, JEWELL CM, CIDLOWSKI JA, HU JM, MUNCK A: Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J Steroid Biochem Mol Biol 65: 91-99, 1998.
11. BONZO JA, CHEN S, GALIJATOVIC A, TUKEY RH: Arsenite inhibition of CYP1A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin is independent of cell cycle arrest. Mol Pharmacol 67: 1247-1256, 2005.
12. BRAKE PB, ZHANG L, JEFCOATE CR: Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids. Mol Pharmacol 54: 825-833, 1998.
13. CELANDER M, HAHN ME, STEGEMAN JJ: Cytochromes P450 (CYP) in the Poeciliopsis lucida hepatocellular carcinoma cell line (PLHC-1): dose- and time-dependent glucocorticoid potentiation of CYP1A induction without induction of CYP3A. Arch Biochem Biophys 329: 113-122, 1996.
14. CIDLOWSKI JA, CIDLOWSKI NB: Glucocorticoid receptors and the cell cycle: evidence that the accumulation of glucocorticoid receptors during the S phase of the cell cycle is dependent on ribonucleic acid and protein synthesis. Endocrinology 110: 1653-1662, 1982.
15. CSABA G, MAG O, INCZEFI-GONDA A, SZEBERENYI S: Persistent influence of neonatal 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment on glucocorticoid receptors and on the microsomal enzyme system. J Dev Physiol 15: 337-340, 1991.
16. CUTHILL S, POELLINGER L, GUSTAFSSON JA: The receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse hepatoma cell line Hepa 1c1c7. A comparison with the glucocorticoid receptor and the mouse and rat hepatic dioxin receptors. J Biol Chem 262: 3477-3481, 1987.
17. DAUJAT M, CHARRASSE S, FABRE I, LESCA P, JOUNAIDI Y, LARROQUE C, POELLINGER L, MAUREL P: Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. Eur J Biochem 237: 642-652, 1996.
18. DENIS M, CUTHILL S, WIKSTROM AC, POELLINGER L, GUSTAFSSON JA: Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor. Biochem Biophys Res Commun 155: 801-807, 1988.
19. DENIS M, WILHELMSSON A, CUTHILL S, POELLINGER L, GUSTAFSSON JA: Structural differences between the glucocorticoid, dioxin and oxysterol receptors from rat liver cytosol. Biochem Biophys Res Commun 163: 444-451, 1989.
20. DONATO MT, GOMEZ-LECHON MJ, CASTELL JV: A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal Biochem 213: 29-33, 1993.
21. DVOŘÁK Z, ULRICHOVÁ J, MODRIANSKÝ M: Role of microtubules network in CYP genes expression. Curr Drug Metab 6: 545-552, 2005a.
22. DVOŘÁK Z, ULRICHOVÁ J, MODRIANSKÝ M: Role of microtubules network in CYP genes expression. Curr Drug Metab 6: 545-552, 2005b.
23. HINES RN, MATHIS JM, JACOB CS: Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis 9: 1599-1605, 1988.
24. HSU SC, QI M, DEFRANCO DB: Cell cycle regulation of glucocorticoid receptor function. EMBO J 11: 3457-3468, 1992.
25. LAI KP, WONG MH, WONG CK: Modulation of AhR-mediated CYP1A1 mRNA and EROD activities by 17beta-estradiol and dexamethasone in TCDD-induced H411E cells. Toxicol Sci 78: 41-49, 2004.
26. LIN FH, STOHS SJ, BIRNBAUM LS, CLARK G, LUCIER GW, GOLDSTEIN JA: The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol 108: 129-139, 1991.
27. MATHIS JM, PROUGH RA, HINES RN, BRESNICK E, SIMPSON ER: Regulation of cytochrome P-450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes. Arch Biochem Biophys 246: 439-448, 1986a.
28. MATHIS JM, PROUGH RA, SIMPSON ER: Synergistic induction of monooxygenase activity by glucocorticoids and polycyclic aromatic hydrocarbons in human fetal hepatocytes in primary monolayer culture. Arch Biochem Biophys 244: 650-661, 1986b.
29. MIMURA J, FUJII-KURIYAMA Y: Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619: 263-268, 2003.
30. MIZUYACHI K, SON DS, ROZMAN KK, TERRANOVA PF: Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin: reduction of cyclooxygenase-2 in the blockage of ovulation. Reprod Toxicol 16: 299-307, 2002.
31. PASCUSSI JM, JOUNAIDI Y, DROCOURT L, DOMERGUE J, BALABAUD C, MAUREL P, VILAREM MJ: Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260: 377-381, 1999.
32. PASCUSSI JM, DROCOURT L, FABRE JM, MAUREL P, VILAREM MJ: Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58: 361-372, 2000a.
33. PASCUSSI JM, GERBAL-CHALOIN S, FABRE JM, MAUREL P, VILAREM MJ: Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58: 1441-1450, 2000b.
34. PASCUSSI JM, DVOŘÁK Z, GERBAL-CHALOIN S, ASSENAT E, MAUREL P, VILAREM MJ: Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 35: 255-268, 2003.
35. PASCUSSI JM, DVOŘÁK, Z., GERBAL-CHALOIN, S., ASSENAT, E., DROCOURT, L., MAUREL, P., VILAREM, M.J. Regulation of xenobiotic detoxification by PXR, CAR, GR, VDR and SHP receptors: Consequences in physiology. In: Transcription Factors, STARKE K, (ed), Springer-Verlag, Berlin, 2004, pp 409-435.
36. PASCUSSI JM, GERBAL-CHALOIN S, DROCOURT L, ASSENAT E, LARREY D, PICHARD-GARCIA L, VILAREM MJ, MAUREL P: Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 34: 633-664, 2004.
37. PRATT RM: Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate. Environ Health Perspect 61: 35-40, 1985.
38. SANTINI RP, MYRAND S, ELFERINK C, REINERS JJ, JR.: Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase. J Pharmacol Exp Ther 299: 718-728, 2001.
39. SCHOLLER A, HONG NJ, BISCHER P, REINERS JJ, JR.: Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole. Mol Pharmacol 45: 944-954, 1994.